Alpine Immune Sciences, Inc.
(Deutsche Boerse AG : NVLS)

( )
NVLS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.67%176.001.2%$592.87m
CELGCelgene Corporation
0.00%89.201.2%$509.00m
BIIBBiogen Inc.
1.05%272.281.2%$467.20m
GILDGilead Sciences, Inc.
0.04%73.280.9%$411.00m
INCYIncyte Corporation
0.00%62.992.5%$245.54m
REGNRegeneron Pharmaceuticals, Inc.
0.00%316.172.7%$243.99m
VRTXVertex Pharmaceuticals Incorporated
-1.28%153.161.9%$217.79m
ALXNAlexion Pharmaceuticals, Inc.
8.07%114.602.0%$216.65m
ILMNIllumina, Inc.
0.00%231.193.5%$196.58m
NKTRNektar Therapeutics
0.15%82.716.0%$194.70m
AAgilent Technologies, Inc.
0.00%65.811.5%$162.73m
ALNYAlnylam Pharmaceuticals, Inc
0.00%94.339.8%$134.72m
BLUEBluebird Bio, Inc.
0.00%162.6015.8%$118.46m
EXASExact Sciences Corporation
1.17%45.8025.7%$111.25m
BMRNBioMarin Pharmaceutical Inc.
0.00%81.534.4%$101.49m

Company Profile

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded on July 24, 2017 and is headquartered in Seattle, WA.